Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in SAREPTA THERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 276,955 shares of SRPT (SAREPTA THERAPEUTICS INC), worth $6M as of 2026-Q1. The position was increased (+3.9% shares). SRPT represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$6M
Current Shares
276,955
Total Value Change
-$41.6M
Total Shares Change
-24,526
Other major holders of SRPT: BNP PARIBAS FINANCIAL MARKETS, DnB Asset Management AS
Increased |
| 276,955 |
+3.9% |
| $6M |
| 0.0% |
| $15.87 |
28 |
| 2025-Q4 | Increased | 266,549 | +14.2% | $5.7M | 0.0% | $21.49 | 31 |
| 2025-Q3 | Decreased | 233,461 | -41.1% | $4.5M | 0.0% | $18.82 | 0 |
| 2025-Q2 | Decreased | 396,167 | -14.5% | $6.8M | 0.0% | $17.11 | 0 |
| 2025-Q1 | Increased | 463,342 | +54.8% | $29.6M | 0.0% | $70.41 | 41 |
| 2024-Q4 | Increased | 299,301 | +11.6% | $36.4M | 0.0% | $121.19 | 32 |
| 2024-Q3 | Decreased | 268,203 | -11.0% | $33.5M | 0.0% | $124.53 | 0 |
| 2024-Q2 | Increased | 301,481 | +87.2% | $47.6M | 0.0% | $158.00 | 46 |